Immix Biopharma, Inc. - Common Stock (NQ:IMMX)

7.715 -0.265 (-3.32%)

Delayed Quote Updated: 9:58 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immix Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 22, 2022

Via Benzinga

Immix Biopharma Announces 16th Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial

December 20, 2022

From Immix Biopharma, Inc.

Via GlobeNewswire

ImmixBio Ships Tislelizumab for Patient Dosing in its Combination Clinical Trial with IMX-110 in Advanced Solid Tumors

December 19, 2022

From Immix Biopharma, Inc.

Via GlobeNewswire

Dow Drops Over 300 Points After Fed Raises Key Overnight Interest Rate By 50 bps ↗

December 14, 2022

U.S. stocks turned lower toward the end of trading, after the Federal Reserve announced its policy decision.

Via Benzinga

Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session ↗

December 14, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

Dow Surges Over 100 Points; Charter Communications Shares Slide ↗

December 14, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Wednesday

Via Benzinga

Why Immix Biopharma Shares Are Surging Today? ↗

December 14, 2022

Immix Biopharma Inc (NASDAQ: IMMX) announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 (formerly HBI0101).

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 14, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 14, 2022

Via Benzinga

Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial

December 13, 2022

From Immix Biopharma, Inc.

Via GlobeNewswire

Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloidosis (100% Complete Responses)

December 14, 2022

From Immix Biopharma, Inc.

Via GlobeNewswire

ImmixBio Releases and Ships Scaled-Up GMP Batches of IMX-110 for Clinical Trial Patient Dosing

December 12, 2022

From Immix Biopharma, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 02, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 27, 2022

On Thursday, 111 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 26, 2022

On Wednesday, 53 companies reached new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 15, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 18, 2022

During Tuesday's session, 78 companies made new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 19, 2022

Via Benzinga

121 Stocks That Hit Their 52-Week Low ↗

October 14, 2022

New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

June 07, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) gained 70% to $0.4900 after the company entered a sponsored research agreement under which in vivo preclinical data will be generated from Kiromic's Gamma...

Via Benzinga

Dow Brushes Off Rate Hike Fears, Microsoft Warning ↗

June 02, 2022

Investors are attempting to brush off comments from Federal Reserve Vice President Lael Brainard, which reignited rate hike concerns.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 02, 2022

Via Benzinga

74 Biggest Movers From Yesterday ↗

June 03, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 02, 2022

Good morning, investors! It's time to start another day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

53 Stocks Moving In Thursday's Mid-Day Session ↗

June 02, 2022

Gainers

Via Benzinga

24 Stocks Moving in Thursday's Pre-Market Session ↗

June 02, 2022

Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) rose 42.2% to $2.63 in pre-market trading after declining around 14% on Wednesday. Immix Biopharma, last month, announced positive interim data from an...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 01, 2022

Gainers

Via Benzinga

77 Biggest Movers From Yesterday ↗

June 01, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.